Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring tec... Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. Its operations include identifying and developing potential product candidates, executing preclinical studies, establishing manufacturing capabilities, acquiring technology, organizing and staffing the Company, business planning, establishing the company's intellectual property portfolio, raising capital, and providing general and administrative support for these operations. Mehr anzeigen
Fast Track designation is designed to expedite clinical development and regulatory review timelines Enrolling patients in the GLEAM trial for SC291 in B-cell mediated autoimmune diseases...
SEATTLE, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will...
Continue to advance hypoimmune technology in three trials across five indications in type 1 diabetes, B-cell mediated autoimmune diseases, and oncology Enrolling patients in the...
Prioritize clinical and preclinical development on type 1 diabetes (UP421 and SC451), B-cell mediated autoimmune diseases (SC291), refractory B-cell malignancies (SC262), and the fusogen platform...
Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence PR Newswire CAMBRIDGE, Masss. and LONDON, Oct...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.17 | -8.99470899471 | 1.89 | 2.04 | 1.55 | 2929671 | 1.79766548 | CS |
| 4 | -0.68 | -28.3333333333 | 2.4 | 3.07 | 1.55 | 2050347 | 2.22188049 | CS |
| 12 | -2.49 | -59.1448931116 | 4.21 | 4.445 | 1.55 | 1594046 | 2.92544664 | CS |
| 26 | -3.96 | -69.7183098592 | 5.68 | 7.4 | 1.55 | 1660375 | 4.2734225 | CS |
| 52 | -2.51 | -59.3380614657 | 4.23 | 12 | 1.55 | 2107638 | 6.20146624 | CS |
| 156 | -14.75 | -89.5567698846 | 16.47 | 16.79 | 1.55 | 1525573 | 5.99199362 | CS |
| 260 | -36.18 | -95.4617414248 | 37.9 | 44.6 | 1.55 | 1329964 | 8.01569945 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
